🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To determine the dose, safety, radiation dosimetry and efficacy of 177Lu-rh...
Status
Recruiting
Location
Biogenix Molecular LLC
Start Date
2022-07-20
Trial ID
NCT05413850
Treatments Being Tested
The use of lung ultrasound is instrumental in the evaluation of many chest ...
Status
Recruiting
Location
Fondazione Policlinico Universitario A. Gemelli IRCCS
Start Date
2023-03-22
Trial ID
NCT06068647
Treatments Being Tested
The purpose of the study is to assess the fibrin structure marker in the pl...
Status
Completed
Location
Internal Medecine Department - Adults Pole and Hematology Laboratory Hôpital Louis Mourier (AP-HP)
Start Date
2015-08
Trial ID
NCT02552381
Treatments Being Tested
The oscillations of ultrasound (US) contrast agent microbubbles under their...
Status
Completed
Location
Service d'Hépatogastro-entérologie CHRU de TOURS
Start Date
2019-10-01
Trial ID
NCT03458975
Treatments Being Tested
This clinical trial aims to evaluate whether a 2 week regimen of transcrani...
Status
Completed
Location
University of Arizona
Start Date
2020-08-13
Trial ID
NCT04375072
Heated, humidified high-flow air (HHHFA) devices improve airway clearance. ...
Status
Completed
Location
University of Iowa
Start Date
2021-02-24
Trial ID
NCT03959982
The goal of this observational study is to characterise the relationships b...
Status
Recruiting
Location
Royal Infirmary of Edinburgh
Start Date
2025-07-31
Trial ID
NCT07472049
The overall aims of this protocol are to determine whether prenatal supplem...
Status
Recruiting
Location
Indiana University
Start Date
2023-10-11
Trial ID
NCT06106646
This trial is to compare the efficacy of NOAC(Novel Oral Anticoagulants) wi...
Status
Completed
Location
Queen Mary Hospital
Start Date
2018-03-15
Trial ID
NCT03284827
This compares the effects of nivolumab at a fixed dose of 40 mg with chemo-...
Status
Recruiting
Location
National Research Center for Hematology
Start Date
2022-04-01
Trial ID
NCT06188676